M1 cells can stimulate antitumoral immune responses by releasing TNF-α and nitric oxide; however, M2 cells can express VEGF, IL-10, TGF-β, and indoleamine 2,3-dioxygenase (IDO), leading to tumor development [16,37,38]. This evidence concerns the gene VEGFA and neoplasm.